Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 27 results.
User Information
Export Records
  1. 2.   Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1
  2. Martin, Pat; Naranbhai, Vivek; Shea, Patrick R.; Qi, Ying; Ramsuran, Veron; Vince, Nicolas; Gao, Xiaojiang; Thomas, Rasmi; Brumme, Zabrina L.; Carlson, Jonathan M.; Wolinsky, Steven M.; Goedert, James J.; Walker, Bruce D.; Segal, Florencia P.; Deeks, Steven G.; Haas, David W.; Migueles, Stephen A.; Connors, Mark; Michael, Nelson; Fellay, Jacques; Gostick, Emma; Llewellyn-Lacey, Sian; Price, David A.; Lafont, Bernard A.; Pymm, Phillip; Saunders, Philippa M.; Widjaja, Jacqueline; Wong, Shu Cheng; Vivian, Julian P.; Rossjohn, Jamie; Brooks, Andrew G.; Carrington, Mary
  3. Journal of Clinical Investigation. 2018, May 01; 128(5): 1903-1912.
  1. 3.   Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B
  2. Vivian, J. P.; Duncan, R. C.; Berry, R.; O'Connor, G. M.; Reid, H. H.; Beddoe, T.; Gras, S.; Saunders, P. M.; Olshina, M. A.; Widjaja, J. M. L.; Harpur, C. M.; Lin, J.; Maloveste, S. M.; Price, D. A.; Lafont, B. A. P.; McVicar, D. W.; Clements, C. S.; Brooks, A. G.; Rossjohn, J.
  3. Nature. 2011, Nov; 479(7373): 401-U155.
  1. 4.   The Shaping of Modern Human Immune Systems by Multiregional Admixture with Archaic Humans
  2. Abi-Rached, L.; Jobin, M. J.; Kulkarni, S.; McWhinnie, A.; Dalva, K.; Gragert, L.; Babrzadeh, F.; Gharizadeh, B.; Luo, M.; Plummer, F. A.; Kimani, J.; Carrington, M.; Middleton, D.; Rajalingam, R.; Beksac, M.; Marsh, S. G. E.; Maiers, M.; Guethlein, L. A.; Tavoularis, S.; Little, A. M.; Green, R. E.; Norman, P. J.; Parham, P.
  3. Science. 2011, Oct; 333(6052): 89-94.
  1. 5.   Human Leukocyte Antigen Genotype and Risk of HIV Disease Progression before and after Initiation of Antiretroviral Therapy
  2. Kuniholm, M. H.; Gao, X. J.; Xue, X. N.; Kovacs, A.; Anastos, K.; Marti, D.; Greenblatt, R. M.; Cohen, M. H.; Minkoff, H.; Gange, S. J.; Fazzari, M.; Young, M. A.; Strickler, H. D.; Carrington, M.
  3. Journal of Virology. 2011, Oct; 85(20): 10826-10833.
  1. 6.   HIV-1 adaptation to NK-cell-mediated immune pressure
  2. Alter, G.; Heckerman, D.; Schneidewind, A.; Fadda, L.; Kadie, C. M.; Carlson, J. M.; Oniangue-Ndza, C.; Martin, M.; Li, B.; Khakoo, S. I.; Carrington, M.; Allen, T. M.; Altfeld, M.
  3. Nature. 2011, Aug; 476(7358): 96-+.
  1. 7.   Common HIV-1 Peptide Variants Mediate Differential Binding of KIR3DL1 to HLA-Bw4 Molecules
  2. Fadda, L.; O'Connor, G. M.; Kumar, S.; Piechocka-Trocha, A.; Gardiner, C. M.; Carrington, M.; McVicar, D. W.; Altfeld, M.
  3. Journal of Virology. 2011, Jun; 85(12): 5970-5974.
  1. 8.   HLA-A*7401-Mediated Control of HIV Viremia Is Independent of Its Linkage Disequilibrium with HLA-B*5703
  2. Matthews, P. C.; Adl, E.; Listgarten, J.; Leslie, A.; Mkhwanazi, N.; Carlson, J. M.; Harndahl, M.; Stryhn, A.; Payne, R. P.; Ogwu, A.; Huang, K. H. G.; Frater, J.; Paioni, P.; Kloverpris, H.; Jooste, P.; Goedhals, D.; van Vuuren, C.; Steyn, D.; Riddell, L.; Chen, F.; Luzzi, G.; Balachandran, T.; Ndung'u, T.; Buus, S.; Carrington, M.; Shapiro, R.; Heckerman, D.; Goulder, P. J. R.
  3. Journal of Immunology. 2011, May; 186(10): 5675-5686.
  1. 9.   HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
  2. McCormack, M.; Alfirevic, A.; Bourgeois, S.; Farrell, J. J.; Kasperaviciute, D.; Carrington, M.; Sills, G. J.; Marson, T.; Jia, X. M.; de Bakker, P. I. W.; Chinthapalli, K.; Molokhia, M.; Johnson, M. R.; O'Connor, G. D.; Chaila, E.; Alhusaini, S.; Shianna, K. V.; Radtke, R. A.; Heinzen, E. L.; Walley, N.; Pandolfo, M.; Pichler, W.; Park, B. K.; Depondt, C.; Sisodiya, S. M.; Goldstein, D. B.; Deloukas, P.; Delanty, N.; Cavalleri, G. L.; Pirmohamed, M.
  3. New England Journal of Medicine. 2011, Mar; 364(12): 1134-1143.
  1. 10.   KIR Polymorphisms Modulate Peptide-Dependent Binding to an MHC Class I Ligand with a Bw6 Motif
  2. Colantonio, A. D.; Bimber, B. N.; Neidermyer, W. J.; Reeves, R. K.; Alter, G.; Altfeld, M.; Johnson, R. P.; Carrington, M.; O'Connor, D. H.; Evans, D. T.
  3. Plos Pathogens. 2011, Mar; 7(3): 13.
  1. 11.   Spontaneous Control of HCV Is Associated With Expression of HLA-B*57 and Preservation of Targeted Epitopes
  2. Kim, A. Y.; Kuntzen, T.; Timm, J.; Nolan, B. E.; Baca, M. A.; Reyor, L. L.; Berical, A. C.; Feller, A. J.; Johnson, K. L.; Zur Wiesch, J. S.; Robbins, G. K.; Chung, R. T.; Walker, B. D.; Carrington, M.; Allen, T. M.; Lauer, G. M.
  3. Gastroenterology. 2011, Feb; 140(2): 686-U434.
  1. 12.   Increased plasmacytoid dendritic cell maturation and natural killer cell activation in HIV-1 exposed, uninfected intravenous drug users
  2. Tomescu, C.; Duh, F. M.; Lanier, M. A.; Kapalko, A.; Mounzer, K. C.; Martin, M. P.; Carrington, M.; Metzger, D. S.; Montaner, L. J.
  3. Aids. 2010, Sep; 24(14): 2151-2160.
  1. 13.   Assembly and intracellular trafficking of HLA-B*3501 and HLA-B*3503
  2. Thammavongsa, V.; Schaefer, M.; Filzen, T.; Collins, K. L.; Carrington, M.; Bangia, N.; Raghavan, M.
  3. Immunogenetics. 2009, Dec; 61(11-12): 703-716.
  1. 15.   Novel KIR3DL1 alleles and their expression levels on NK cells: Convergent evolution of KIR3DL1 phenotype variation?
  2. Thomas, R.; Yamada, E.; Alter, G.; Martin, M. P.; Bashirova, A. A.; Norman, P. J.; Altfeld, M.; Parham, P.; Anderson, S. K.; McVicar, D. W.; Carrington, M.
  3. Journal of Immunology. 2008 180(10): 6743-6750.
  1. 16.   Analysis of the linker for activation of T cells and the linker for activation of B cells in natural killer cells reveals a novel signaling cassette, dual usage in ITAM signaling, and influence on development of the Ly49 repertoire
  2. Whittaker, G. C.; Burshtyn, D. N.; Orr, S. J.; Quigley, L.; Hodge, D. L.; Pascal, R.; Zhang, W. G.; McVicar, D. W.
  3. Blood. 2008 112(7): 2869-2877.
  1. 17.   Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection
  2. Pascal, V.; Yamada, E.; Martin, M. P.; Alter, G.; Altfeld, M.; Metcalf, J. A.; Baseler, M. W.; Adelsberger, J. W.; Carrington, M.; Anderson, S. K.; McVicar, D. W.
  3. Journal of Immunology. 2007, Aug; 179(3): 1625-1633.
  1. 18.   Mamu-B*08-positive macaques control simian immunodeficiency virus replication
  2. Loffredo, J. T.; Maxwell, J.; Qi, Y.; Glidden, C. E.; Borchardt, G. J.; Soma, T.; Bean, A. T.; Beal, D. R.; Wilson, N. A.; Rehrauer, W. M.; Lifson, J. D.; Carrington, M.; Watkins, D. I.
  3. Journal of Virology. 2007, Aug; 81(16): 8827-8832.
  1. 19.   Lack of KIR3DS1 binding to MHC class I Bw4 tetramers in complex with CD8(+) T cell epitopes
  2. Gillespie, G. M. A.; Bashirova, A.; Dong, T.; McVicar, D. W.; Rowland-Jones, S. L; Carrington, M.
  3. Aids Research and Human Retroviruses. 2007, Mar; 23(3): 451-455.
  1. 20.   HLA-B Bw4 alleles and HIV-1 transmission in heterosexual couples
  2. Welzel, T. M.; Gao, X. J.; Pfeiffer, R. M.; Martin, M. P.; O'Brien, S. J.; Goedert, J. J.; Carrington, M.; O'Brien, T. R.
  3. Aids. 2007, Jan; 21(2): 225-229.
  1. 21.   Diversity of MICA and linkage disequilibrium with HLA-B in two North American populations
  2. Gao, X. J.; Single, R. M.; Karacki, P.; Marti, D.; O'Brien, S. J.; Carrington, M.
  3. Human Immunology. 2006, MAR; 67(3, Special Issue): 152-158.
  1. 22.   Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopes
  2. Frahm, N.; Kiepiela, P.; Adams, S.; Linde, C. H.; Hewitt, H. S.; Sango, K.; Feeney, M. E.; Addo, M. M.; Lichterfeld, M.; Lahaie, M. P.; Pae, E.; Wurcel, A. G.; Roach, T.; St John, M. A.; Altfeld, M.; Marincola, F. M.; Moore, C.; Mallal, S.; Carrington, M.; Heckerman, D.; Allen, T. M.; Mullins, J. I.; Korber, B. T.; Goulder, P. J. R.; Walker, B. D.; Br, er
  3. Nature Immunology. 2006, FEB; 7(2): 173-178.
  1. 23.   HLA class I diversity among rural rainforest inhabitants in Cameroon: identification of A*2612-B*4407 haplotype
  2. Torimiro, J. N.; Carr, J. K.; Wolfe, N. D.; Karacki, P.; Martin, M. P.; Gao, X.; Tamoufe, U.; Thomas, A.; Ngole, E. M.; Birx, D. L.; McCutchan, F. E.; Burke, D. S.; Carrington, M.
  3. Tissue Antigens. 2006, JAN; 67(1): 30-37.
  1. 24.   Effects of MHC class I on HIV/SIV disease in primates
  2. Carrington, M.; Bontrop, R. E.
  3. Aids. 2002 16(Suppl. 4): S105-S114.
  1. 25.   Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS
  2. Gao, X. J.; Nelson, G. W.; Karacki, P.; Martin, M. P.; Phair, J.; Kaslow, R.; Goedert, J. J.; Buchbinder, S.; Hoots, K.; Vlahov, D.; O'Brien, S. J.; Carrington, M.
  3. New England Journal of Medicine. 2001 344(22): 1668-1675.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel